Go to the list of all blogs
M. Benett's Avatar
published in Blogs
May 13, 2026
Oracle (ORCL): Cloud Surge and AI Momentum Amid Volatility

Oracle (ORCL): Cloud Surge and AI Momentum Amid Volatility

Key Takeaways

  • Oracle's cloud revenue surged 44% in recent quarters, driven by explosive 84% growth in cloud infrastructure (IaaS), positioning it as a key AI player.
  • Remaining performance obligations (RPO, a measure of future committed revenue) hit $553 billion, up 325% year-over-year, signaling robust long-term demand.
  • Analysts maintain a consensus "Buy" rating with an average price target around $260, implying significant upside potential.
  • Recent volatility reflects broader AI sector concerns, but strong Q3 earnings beat estimates with raised FY2027 revenue guidance to $90 billion.
  • New board appointment and partnerships underscore healthcare and security expansions amid ongoing data center buildouts.

A Look at ORCL's Recent Market Action

I've been following Oracle Corporation (ORCL) closely through these volatile weeks, as the stock mirrors swings in the broader AI and tech sectors. Shares took sharp hits amid worries about OpenAI's growth slowdown and the heavy capital expenditures needed for data centers, but they've bounced back on solid cloud performance and fresh analyst upgrades. From what I see, demand for cloud infrastructure remains the key driver, with remaining performance obligations providing clear multi-year visibility. Trading volumes have jumped during major news, highlighting how investors are zeroed in on Oracle's shift from legacy software to high-growth AI cloud services. Overall, the sentiment weighs AI optimism against macro challenges like supply constraints and funding demands.

Recent Developments Shaping ORCL's Price

In the past 30 days, ORCL has experienced notable volatility, driven by earnings results, AI partnerships, analyst updates, and some sector pressures. For fiscal Q3 2026, ended February 28, Oracle posted revenue of $17.19 billion, a 22% year-over-year increase that beat estimates by 1.77%, alongside adjusted EPS of $1.79, topping expectations by 5.29%. Cloud revenue rose 44% to $8.9 billion—more than half of total sales—powered by an 84% jump in cloud infrastructure (IaaS), thanks to demand for AI training and inference. Remaining performance obligations (RPO) reached $553 billion, up 325%, fueled by major AI deals with clients like OpenAI, Meta, and xAI, including some customer-funded arrangements to lighten capex loads.

These figures led to upward FY2027 revenue guidance of $90 billion, 4% above consensus, which initially lifted shares after earnings. But they dipped following reports that OpenAI missed user and revenue goals, pulling down AI-related names like ORCL on growth fears. An April Wall Street Journal piece on OpenAI's slowdown triggered a selloff, with ORCL dropping alongside CoreWeave. AI infrastructure supply issues added to the caution, though analysts such as Arete upgraded ORCL to Buy on May 7, viewing those bottlenecks as a tailwind for incumbents. Oppenheimer hiked its target to $235 from $210 on May 12, pointing to Q4 potential from restructuring and tech spend.

On the strategic front, Oracle added Tomislav Mihaljevic, M.D., Cleveland Clinic CEO, to its board on May 13, bringing valuable healthcare insight as cloud health IT demand grows. Partnerships progressed too, with VoucherCart now on the Oracle Cloud Marketplace for hospitality, Red Rover Health in the partner program, and an expanded Samsung agreement for Java security. Financing closed for a $16 billion Michigan data center campus in late April, geared toward OpenAI and Microsoft workloads to support gigawatt-scale AI capacity. Super Micro slipped on news of losing an Oracle contract, which indirectly shows Oracle's negotiating strength with suppliers.

The price action has tracked these developments: shares surged about 10% premarket on March 10-11 after Q3, pulled back in April on AI jitters, then recovered in early May on upgrades, with typical intraday moves of 4-5%. Macro elements like tech infrastructure outlays and AI hype cycles have magnified the swings, and ORCL has held up better than peers on strong days, even with some YTD softness. The consensus stays bullish, with 36 analysts at Buy and an average target of $261, betting on the cloud path over short-term distractions.

Exploring Trending AI Robots for Smarter Trading

One tool I rely on for navigating volatility like this is Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI Trading Bots. Drawn from hundreds of bots trading thousands of tickers with varied strategies, these use advanced Financial Learning Models (FLMs) and machine learning to adapt in real time. They show strong results, such as annualized returns up to 227%, win rates of 70-80%, and profit factors over 3.0 in areas like semiconductors, aerospace, and energy. Short-term bots (5-15 minutes) deliver 76% annualized gains, while swing traders buying tech ETF dips hit 57-91% returns with 73%+ win rates. Each bot differs in timeframe, risk, and approach—some chase momentum, others buy dips—so the trending list offers a live view of what's working now. I've found it helpful for refining strategies around stocks like ORCL, adding data-driven edge without the guesswork.

ORCL's 2026 Outlook and What to Watch

Looking ahead in 2026, I'm keeping a close eye on Oracle's cloud infrastructure growth as AI adoption ramps up. FY2026 revenue should land near $67-88 billion, led by cloud and 70%+ IaaS expansion from projects like the $16 billion Michigan campus and customer-funded GPU pacts. Ties with Nvidia, OpenAI, Meta, and xAI—including OpenAI's $300 billion cloud pledge—set Oracle up to handle enduring AI workloads, possibly lifting OCI into hyperscaler elite.

That said, risks are real: capex of $45-50 billion (via debt/equity), debt over $100 billion, and chip/power supply hurdles. Competition from AWS, Azure, and Google Cloud continues, as does regulatory focus on AI ethics and privacy. Upside could come from agentic AI in apps like Fusion Cloud recruiting, healthcare boosted by the new board member, and markets like Africa clinical trials. Success will hinge on cost control, converting that $553 billion RPO, and growing margins (currently 31.9% operating). I'll be watching Q4 earnings in June for FY2027 updates and AI contract progress. I also checked this using Tickeron’s AI Screener to gauge how ORCL stacks up against industry peers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: ORCL

ORCL in upward trend: price rose above 50-day moving average on August 21, 2026

ORCL moved above its 50-day moving average on August 21, 2026 date and that indicates a change from a downward trend to an upward trend. In of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ORCL's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where ORCL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ORCL just turned positive on July 22, 2026. Looking at past instances where ORCL's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for ORCL crossed bullishly above the 50-day moving average on August 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCL advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORCL as a result. In of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ORCL broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ORCL entered a downward trend on August 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.236) is normal, around the industry mean (22.706). P/E Ratio (25.123) is within average values for comparable stocks, (70.701). Projected Growth (PEG Ratio) (0.828) is also within normal values, averaging (2.165). Dividend Yield (0.014) settles around the average of (0.021) among similar stocks. P/S Ratio (6.337) is also within normal values, averaging (111.934).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ORCL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Twilio (NYSE:TWLO), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 33.88B. The market cap for tickers in the group ranges from 48.8K to 3.59T. MSFT holds the highest valuation in this group at 3.59T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was -1%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 19%. WETO experienced the highest price growth at 216%, while YYAI experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was -11% and the average quarterly volume growth was -60%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 71
Price Growth Rating: 55
SMR Rating: 79
Profit Risk Rating: 91
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
ORCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of a diversified line of business software products

Industry ComputerCommunications

Profile
Details
Industry
Packaged Software
Address
2300 Oracle Way
Phone
+1 737 867-1000
Employees
164000
Web
https://www.oracle.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.